Company
LumiMeds
LumiMeds publishes compounded semaglutide and compounded tirzepatide, from $89 to $125 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from lumimeds.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to LumiMeds
We earn nothing from this link. LumiMeds has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Starting price (term length not specified on this page)
first month, including the required fees on record · Starting price (term length not specified on this page)
Terms
| Membership | None. “No membership required.” |
|---|
Not yet checked: pharmacy, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Product pages say 'MONTHLY, 3, 6, AND 12 MONTH OPTIONS AVAILABLE' but only one 'as low as' figure per drug is shown in static text, so it is unclear which term length the $89 and $125 headline prices correspond to (likely the longest/cheapest tier). /pricing redirected with a 404. NAD+ is a separate product 'From $ 119 /month', not a GLP-1.
Before you act
Cite this
Treatment Registry. (2026). LumiMeds: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/lumimeds